Steven R. Gullans Ph.D., Director at Gemphire Therapeutics Inc. (GEMP), bought 806,025 shares at $10.00 ($7.1M) on 2016-08-10, disclosed to the SEC on 2016-08-12.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.71 | 306,025 | $2.1M | 29.1% |
| 2 | $10.00 | 500,000 | $5.0M | 70.9% |
| Total | $8.75 avg | 806,025 | $7.1M | 100% |
| Filing → |
| GEMP | BUY | 2017-03-14 | $1000K | — | Filing → |
| TTPH | BUY | 2014-05-21 | $231K | — | Filing → |
| TTPH | BUY | 2013-03-27 | $3.5M | — | Filing → |